Literature DB >> 6498082

Interaction of diethylaminoreserpine with cells of a transplantable tumour in vivo.

S Lehnert.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6498082      PMCID: PMC1976995          DOI: 10.1038/bjc.1984.267

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  8 in total

1.  An in vitro assay to measure the viability of KHT tumor cells not previously exposed to culture conditions.

Authors:  J E Thomson; A M Rauth
Journal:  Radiat Res       Date:  1974-05       Impact factor: 2.841

2.  Oxygenation status of a transplantable tumor during fractionated radiation therapy.

Authors:  L M Van Putten; R F Kallman
Journal:  J Natl Cancer Inst       Date:  1968-03       Impact factor: 13.506

3.  The effect of intercellular contact on the radiation sensitivity of KHT sarcoma cells.

Authors:  R P Hill; R Ng; B F Warren; R S Bush
Journal:  Radiat Res       Date:  1979-01       Impact factor: 2.841

4.  Factors influencing the quantitative estimation of the in vivo survival of cells from solid tumors.

Authors:  R F Kallman; G Silini; L M Van Putten
Journal:  J Natl Cancer Inst       Date:  1967-09       Impact factor: 13.506

Review 5.  The biological fate of reserpine.

Authors:  R E Stitzel
Journal:  Pharmacol Rev       Date:  1976-09       Impact factor: 25.468

6.  Radioprotection of normal and malignant tissue in the mouse by diethylaminoreserpine.

Authors:  S Lehnert; G Fisher; G Methot
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1981-07

7.  Toxicity of diethylaminoreserpine to a transplantable tumor: the significance of the presence of hypoxic cells.

Authors:  S Lehnert
Journal:  Cancer Res       Date:  1982-08       Impact factor: 12.701

8.  Toxicity to tumour cells of diethylaminoreserpine.

Authors:  S Lehnert
Journal:  Br J Cancer Suppl       Date:  1980-04
  8 in total
  1 in total

1.  In vivo toxicity of phenothiazines to cells of a transplantable tumor.

Authors:  S Lehnert
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.